Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by bionicjoeon Jun 26, 2019 8:19am
60 Views
Post# 29863845

RE:RE:RE:RE:RE:RE:news

RE:RE:RE:RE:RE:RE:news
skier59 wrote: That's not your concern Johnny BJ, because as far as we know you are not a Shareholder. Yes we are working to register up to 19 additional sites, but they are not expected to start until those 54 cent warrants come in, which is only about 7 months. Don't worry about our money situation, we here in Canada have it covered with Grants until we can publish some interesting results of the Phase2. No worries, all under control.


bionicjoe wrote: You folks are missing a major disclosure in the PR.

Dr. Shirazi continued by stating, "Theralase is currently working to register up to an additional 19 clinical study sites this year, subject to regulatory and clinical study site approvals.

Warrant money won't be enough to pay to fund 20 sites in the span of the next 6 months. So where will the money come from?




Is that company policy skier59 or your personal belief? By the CEO's statement in the PR it appears they want to have 20 sites up and running before those 54 cents warrants even expire. They are not going to delay treating patients in an additional 19 sites until Feb of 2020. The PR is specific, they want to move ahead as quickly as possible with registering sites in 2019 so again, where will the money come from?

Bullboard Posts